X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (557) 557
thiazolidinediones (433) 433
animals (402) 402
index medicus (380) 380
male (331) 331
pharmacology & pharmacy (312) 312
diabetes mellitus, type 2 - drug therapy (296) 296
endocrinology & metabolism (284) 284
type 2 diabetes (266) 266
hypoglycemic agents - pharmacology (263) 263
diabetes (262) 262
hypoglycemic agents - therapeutic use (252) 252
rats (214) 214
female (210) 210
insulin (202) 202
troglitazone (183) 183
metformin (182) 182
mice (180) 180
insulin resistance (179) 179
diabetes mellitus (166) 166
antidiabetic agents (164) 164
thiazoles - pharmacology (163) 163
hypoglycemic agents (151) 151
middle aged (150) 150
pioglitazone (150) 150
rosiglitazone (147) 147
ppar-gamma (142) 142
insulin-resistance (140) 140
antidiabetic drugs (138) 138
antidiabetic agent (131) 131
glucose (131) 131
chemistry, medicinal (125) 125
thiazolidinedione (124) 124
aged (121) 121
hypoglycemic agents - adverse effects (119) 119
chromans - pharmacology (117) 117
thiazolidinediones - pharmacology (111) 111
blood glucose - metabolism (108) 108
hypoglycemic agents - administration & dosage (107) 107
activated receptor-gamma (103) 103
adult (102) 102
drug therapy (98) 98
antidiabetic thiazolidinedione (95) 95
glycemic control (95) 95
risk factors (94) 94
biochemistry & molecular biology (92) 92
type-2 diabetes-mellitus (88) 88
thiazolidinediones - therapeutic use (85) 85
administration, oral (82) 82
diabetes mellitus, type 2 - blood (80) 80
blood glucose - drug effects (79) 79
research (79) 79
gene-expression (76) 76
oral antidiabetic agent (76) 76
cs-045 (73) 73
medicine, general & internal (73) 73
risk (73) 73
treatment outcome (73) 73
metabolism (72) 72
obesity (72) 72
type 2 diabetes mellitus (72) 72
metformin - therapeutic use (71) 71
thiazoles - therapeutic use (71) 71
medicine, research & experimental (69) 69
antidiabetic (68) 68
insulin - metabolism (66) 66
expression (64) 64
oral antidiabetic drugs (63) 63
hypoglycemic agents - chemistry (62) 62
hypoglycemic agents - pharmacokinetics (62) 62
drug therapy, combination (61) 61
health aspects (61) 61
hyperglycemia (60) 60
mellitus (60) 60
niddm (60) 60
care and treatment (59) 59
dose-response relationship, drug (59) 59
diabetes mellitus, type 2 - complications (58) 58
diabetes therapy (58) 58
adipose-tissue (57) 57
oral antidiabetic agents (57) 57
review (57) 57
rats, wistar (56) 56
in-vitro (55) 55
rats, sprague-dawley (55) 55
therapy (55) 55
drugs (54) 54
ppar gamma - agonists (54) 54
diabetes-mellitus (53) 53
hypoglycemia (53) 53
antidiabetic drug (52) 52
thiazolidinediones - adverse effects (52) 52
insulin - blood (51) 51
mortality (51) 51
physiological aspects (51) 51
resistance (51) 51
diabetes mellitus, type 2 - metabolism (50) 50
internal medicine (50) 50
cells, cultured (49) 49
ligands (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1143) 1143
German (19) 19
French (15) 15
Japanese (6) 6
Spanish (5) 5
Korean (2) 2
Chinese (1) 1
Croatian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 1997, Volume 26, Issue 3, pp. 553 - 573
Journal Article
American Journal of Physiology - Endocrinology And Metabolism, ISSN 0193-1849, 02/2004, Volume 286, Issue 2, pp. 252 - 260
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 08/2003, Volume 112, Issue 4, pp. 608 - 618
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by thiazolidinediones (TZDs) improves insulin resistance by increasing... 
MEDICINE, RESEARCH & EXPERIMENTAL | DEPENDENT DIABETES-MELLITUS | OBESITY | LIPID-METABOLISM | ANTIDIABETIC THIAZOLIDINEDIONE | GLUCOSE | GENE-EXPRESSION | ADIPOCYTE DIFFERENTIATION | TROGLITAZONE ACTION | HUMAN SKELETAL-MUSCLE | RECEPTOR-ALPHA | thiazolidinediones
Journal Article
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 02/2018, Volume 34, Issue 2, pp. e2961 - n/a
Journal Article
Drug Safety, ISSN 0114-5916, 2004, Volume 27, Issue 12, pp. 841 - 856
Thiazolidinediones, also called glitazones, are insulin sensitisers that act as agonists of the peroxisome proliferator-activated receptors-gamma (PPARγ).... 
Diabetes mellitus, treatment | Pioglitazone, adverse reactions | Pioglitazone, therapeutic use | Thiazolidinediones, therapeutic use | Thiazolidinediones, adverse reactions | Insulin, adverse reactions | Rosiglitazone, therapeutic use | Rosiglitazone, adverse reactions | Troglitazone, adverse reactions | Insulin, therapeutic use | Troglitazone, therapeutic use | Type 2 diabetes mellitus, treatment | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | GLYCEMIC CONTROL | ACTIVATED RECEPTOR-GAMMA | COMBINATION THERAPY | BODY-FAT DISTRIBUTION | PULMONARY-EDEMA | ORAL ANTIDIABETIC AGENTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | CONGESTIVE-HEART-FAILURE | TYPE-2 DIABETES-MELLITUS | ENDOTHELIAL GROWTH-FACTOR | Administration, Oral | Humans | Insulin - administration & dosage | Thiazolidinediones - administration & dosage | Thiazolidinediones - adverse effects | Injections | Thiazolidinediones - therapeutic use | Diabetes Mellitus, Type 2 - physiopathology | Chemical and Drug Induced Liver Injury | Edema - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Weight Gain | Insulin - adverse effects | Diabetes Mellitus, Type 2 - complications | Heart Failure - chemically induced | Insulin - therapeutic use
Journal Article